Literature DB >> 27430302

miR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion.

Jun Huang1, Bin Wang1, Ke Hui1, Jin Zeng1, Jinhai Fan1, Xinyang Wang1, Jer-Tsong Hsieh2, Dalin He1, Kaijie Wu1.   

Abstract

Muscle-invasive or metastatic bladder cancer (BCa) has a very poor prognosis; however, its mechanisms remain largely unknown. Previous studies have discovered multiple microRNAs (miRs) that are involved in BCa progression and regarded as potential biomarkers or therapeutic targets. In this study, we demonstrated that miR-92b could uniquely promote cell migration and invasion of BCa cells, but had no effect on cell proliferation. Mechanistically, our data provided evidence to verify that miR-92b was able to directly target DAB2IP, a well-known tumor suppressor, and inhibit epithelial‑mesenchymal transition of BCa cells. Moreover, the increased expression levels of miR-92b were negatively correlated with DAB2IP, and predicted poor prognosis of patients with BCa. Overall, this study reveals a new promising biomarker and its mechanisms contributing to BCa invasion or metastasis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27430302     DOI: 10.3892/or.2016.4940

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  16 in total

Review 1.  Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer.

Authors:  Arianna Bellazzo; Giulio Di Minin; Licio Collavin
Journal:  Cell Death Differ       Date:  2016-11-18       Impact factor: 15.828

2.  Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells.

Authors:  Arianna Bellazzo; Giulio Di Minin; Elena Valentino; Daria Sicari; Denis Torre; Luigi Marchionni; Federica Serpi; Michael B Stadler; Daniela Taverna; Gaia Zuccolotto; Isabella Monia Montagner; Antonio Rosato; Federica Tonon; Cristina Zennaro; Chiara Agostinis; Roberta Bulla; Miguel Mano; Giannino Del Sal; Licio Collavin
Journal:  Cell Death Differ       Date:  2018-03-22       Impact factor: 15.828

3.  MicroRNA-92b inhibits epithelial-mesenchymal transition-induced migration and invasion by targeting Smad3 in nasopharyngeal cancer.

Authors:  Chong Zhao; Feipeng Zhao; Huajun Feng; Shengen Xu; Gang Qin
Journal:  Oncotarget       Date:  2017-09-27

Review 4.  Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets.

Authors:  Cecilia Pop-Bica; Diana Gulei; Roxana Cojocneanu-Petric; Cornelia Braicu; Bogdan Petrut; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2017-07-13       Impact factor: 5.923

5.  CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial-mesenchymal transition and suppressing apoptosis through AKT pathway.

Authors:  Bing Xu; Minjie Zhou; Wencai Qiu; Jueming Ye; Qiming Feng
Journal:  Cancer Med       Date:  2017-04-04       Impact factor: 4.452

6.  Isocitrate dehydrogenase 1-snail axis dysfunction significantly correlates with breast cancer prognosis and regulates cell invasion ability.

Authors:  Wen-Shan Liu; Shih-Hsuan Chan; Hong-Tai Chang; Guan-Cheng Li; Ya-Ting Tu; Hui-Hwa Tseng; Ting-Ying Fu; Hui-Yu Chang; Huei-Han Liou; Luo-Ping Ger; Kuo-Wang Tsai
Journal:  Breast Cancer Res       Date:  2018-04-16       Impact factor: 6.466

7.  miR‑92b promotes autophagy and suppresses viability and invasion in breast cancer by targeting EZH2.

Authors:  Fei Liu; Meixiang Sang; Lingjiao Meng; Lina Gu; Shina Liu; Juan Li; Cuizhi Geng
Journal:  Int J Oncol       Date:  2018-07-18       Impact factor: 5.650

8.  BMPR2 promotes invasion and metastasis via the RhoA-ROCK-LIMK2 pathway in human osteosarcoma cells.

Authors:  Shidong Wang; Tingting Ren; Guangjun Jiao; Yi Huang; Xing Bao; Fan Zhang; Kuisheng Liu; Bingxin Zheng; Kunkun Sun; Wei Guo
Journal:  Oncotarget       Date:  2017-04-24

9.  The endonuclease APE1 processes miR-92b formation, thereby regulating expression of the tumor suppressor LDLR in cervical cancer cells.

Authors:  Yi Sun; Yun Feng; Guiqian Zhang; Ya Xu
Journal:  Ther Adv Med Oncol       Date:  2019-07-10       Impact factor: 8.168

10.  MicroRNA-92b augments sorafenib resistance in hepatocellular carcinoma via targeting PTEN to activate PI3K/AKT/mTOR signaling.

Authors:  Zhouyang Cheng; Qingfeng Ni; Lei Qin; Yang Shi
Journal:  Braz J Med Biol Res       Date:  2021-05-31       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.